Skip To Main Content

Polivy (polatuzumab vedotin-piiq)

Publications icon

Publications

Visit PubMed.gov to browse a listing of published scientific literature about Polivy®.

Polatuzumab vedotin in relapsed or refractory diffuse large b-cell lymphoma
Sehn LH, Herrera AF, Flowers CR, et al. J Clin Oncol 2020;38(2);155-165.

VIEW

Scientific congresses icon

Scientific Congresses

Genentech maintains a presence at in-person and virtual scientific congresses worldwide. Find Genentech-sponsored posters and presentations from recent congresses at Medically.gene.com.

December 11-13, 2022
Onsite/virtual

July 18-22, 2022
Onsite

June 9-12, 2022
Onsite/virtual

June 3-7, 2022
Onsite/virtual

December 11-14, 2021
Onsite/virtual

November 30 – December 3, 2021
Virtual

June 18-22, 2021
Virtual

June 9-17, 2021
Virtual

June 4-8, 2021
Virtual

December 5-8, 2020
Onsite

Clinical trials icon

Clinical Trials

Find information about active clinical research for Polivy® at ClinicalTrials.gov and information about our research at Genentech Clinical Trials.

Additional resources icon

Additional Resources

For additional information or assistance regarding Polivy®, use the links below.

Connect with a Medical Science Liaison

Browse the Genentech Medical Information Library